MedBright AI Investments Inc. Stock

Equities

MBAI

CA58406U1012

Financial & Commodity Market Operators

Market Closed - Canadian Securities Exchange 11:29:09 2024-04-22 am EDT 5-day change 1st Jan Change
0.155 CAD 0.00% Intraday chart for MedBright AI Investments Inc. -8.82% -38.00%
Sales 2022 0.32 0.43 Sales 2023 0.11 0.15 Capitalization 1.57M 2.16M
Net income 2022 -1M -1.37M Net income 2023 - 0 EV / Sales 2022 6,618,187 x
Net cash position 2022 1.06M 1.45M Net Debt 2023 217K 298K EV / Sales 2023 16,539,303 x
P/E ratio 2022
-2.53 x
P/E ratio 2023
-3.66 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 93.72%
More Fundamentals * Assessed data
Dynamic Chart
Southern California Clinic Signs Multi-Year Deal for MedBright AI Investments Inc.'s MedMatrix AI Platform CI
Rejuvenation Medical Group Uses MedMatrix AI Reporter for Centralized Clinic Operations Reporting and Dashboarding CI
Southern California Clinic Uses Medmatrix AI Market Expander to Launch Opening of New Clinic Locations CI
MedBright AI Investments Inc. Announces MedMatrix Completes AI Product Suite CI
MedBright AI Investments Inc. Announces Limmi Disease Insights Platform Being Used in University Hospital Setting to Improve Detection of Kidney Stone Disease Recurrence CI
MedBright AI Investments Inc. announced that it has received CAD 1.398977 million in funding CI
MedBright AI Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 CI
MedBright AI Investments Inc. announced that it expects to receive CAD 2.798977 million in funding CI
Medbright AI?s Medmatrix to Expand Its AI Offerings for Cosmetic Marketing & Clinical Trial Analytics CI
MedBright AI Investments Inc. Announces Rejuvenation Medical Group, Decides to Adopt Medmatrix Across All Its Clinics in Canada CI
MedBright AI Announces Rejuvenation Medical Group, a Large Canadian Clinic Group, as First Int'l Customer for MedMatrix MT
MedBright AI Investments Inc. Announces Rejuvenation Medical Group as First International Customer for Medmatrix, the Ai-Driven Data and Analytics Platform CI
MedBright AI Investments Inc. Announces Chief Executive Officer Changes CI
MedBright AI Investments Inc. Announces CareMEDICA to Implement the Beta Version of Medmatrix into Its Practice CI
MedBright AI Investments Inc. Announces Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform CI
More news
1 week-8.82%
Current month-6.06%
1 month+19.23%
3 months-31.11%
6 months-11.43%
Current year-38.00%
More quotes
1 week
0.15
Extreme 0.145
0.17
1 month
0.13
Extreme 0.125
0.17
Current year
0.13
Extreme 0.125
0.28
1 year
0.05
Extreme 0.05
0.36
3 years
0.05
Extreme 0.05
1.08
5 years
0.05
Extreme 0.05
1.45
10 years
0.03
Extreme 0.025
5.75
More quotes
Managers TitleAgeSince
Chief Executive Officer - Jan. 03
Director of Finance/CFO 46 20-05-24
Director/Board Member 62 21-04-05
Members of the board TitleAgeSince
Director/Board Member 76 13-11-11
Director of Finance/CFO 46 20-05-24
Director/Board Member 45 21-09-16
More insiders
Date Price Change Volume
24-04-22 0.155 0.00% 23,690
24-04-19 0.155 0.00% 171,500
24-04-18 0.155 -8.82% 61,500
24-04-17 0.17 0.00% 42,500
24-04-16 0.17 0.00% 39,500

Delayed Quote Canadian Securities Exchange, April 22, 2024 at 11:29 am EDT

More quotes
MedBright AI Investments Inc. is a capital allocator focused on investing in healthcare technology companies. The Company is engaged in constructing a portfolio of synergistic investments to generate returns for shareholders. The Company is focused on significant near-term and midterm opportunities with potential returns while maintaining a commitment to governance. It is focused on investing in technology and artificial intelligence companies, combined with healthcare operators.
More about the company